Our new report indicates a growing challenge in cancer care access, driven by a widening gap between the number of available oncologists and increasing patient demand.

Learn more about the State of the Oncology Workforce in America: brnw.ch/21wWsrE
#ASCOQLTY25

Meet the amazing co-chairs for our upcoming 9th Annual Patient-Centered Approach to Clinical Trials Conference! Don’t miss this chance to connect, learn, and collaborate on October 28th & 29th! Register today at tinyurl.com/pact-2025

📢 Attention #RTTs! Take this 5–10 min survey on incident reporting & attitudes across Europe. Your input helps improve #safety & #quality in #radiotherapy.
🔒 Anonymous
🧾 Ethically approved
📅 31 October
👉 bit.ly/3KvQRiO
📌Supported by ESTRO

The Lancet: Cancer deaths expected to rise to over 18 million in 2050—an increase of nearly 75% from 2024, study forecasts Globally, the number of new cancer cases has more than doubled since 1990 to 18.5 million in 2023, while the number of cancer deaths increased 74% to 10.4 million (both excluding non-melanoma skin can...

The Lancet: Cancer deaths expected to rise to over 18 million in 2050—an increase of nearly 75% from 2024, study forecasts

www.healthdata.org/news-events/...

Building an appraisal framework for radiotherapy innovations in a value-based context: The ESTRO-Value-based radiation oncology categorisation system Radiation oncology is a fundamental component of cancer management, with the demand expected to increase both in volume and in complexity due to evolving demographics, changing treatment patterns and ...

Building an appraisal framework for radiotherapy innovations in a value-based context: The ESTRO-Value-based radiation oncology categorisation system - Radiotherapy and Oncology www.thegreenjournal.com/article/S016...

Defining Melanoma quality indicators: A Modified Delphi Approach:
doi.org/10.1016/j.ej...

Will your study change the world? This AI tool predicts the impact of your research A tool called Funding the Frontier visualizes all the downstream impacts of funding — and predicts which studies will have the biggest societal impact.

A tool called Funding the Frontier predicts which studies will have the biggest societal impact

go.nature.com/48OtD18

Cancer Grand Challenges announces 12 shortlisted teams for prizes up to £20M - The Cancer Letter Twelve leading research teams from around the world have been shortlisted for Cancer Grand Challenges’ fifth funding round. The teams will present final proposals to a panel of leading international scientists in December, with winners receiving up to £20 million each. To access this subscriber-only content please log in or subscribe.If your institution has a […]

Cancer Grand Challenges (@cancergrand.bsky.social) announces 12 shortlisted teams for prizes up to £20M
https://cancerletter.com/in-brief/20250926_9c/

Conclusions • From phase Il primary study, early RT reduces SRE (30% vs. 2%) • More work needed to better predict SRE • Early RT may preserve self-care and functional ability compared to observation • Benefits emerge after about six months • Consider prognosis • Patient-reported outcomes provide insightful and hypothesis-generating findings • Confirmatory Phase Ill randomized controlled trial (NRG-CC014, PREEMPT) is ongoing • Has enrolled 48/280 patients ASTRO 67TH ANNUAL MEETING | September 27 - October 1, 2025

Rockstar #radonc @mskcancercenter.bsky.social resident Dr Kaitlyn Lapen presents at #ASTRO25 on quality of life improvements with early radiation for asymptomatic bone metastasis which may appear after 6 months. Optimal patient selection is key. @astro-org.bsky.social

Sunbeds should be banned in UK, skin cancer experts say Campaigners urge ministers to close tanning salons across country over dangers posed by UV radiation Sunbeds are so dangerous they should be banned in the UK, cancer experts and campaigners say. They have urged ministers to order the closure of the thousands of tanning salons operating across Britain, using public funds to compensate owners if necessary. Continue reading...

Sunbeds should be banned in UK, skin cancer experts say

Highlights from ASTRO25 Day 1 - OncoDaily Highlights from ASTRO25 Day 1 / Annual Meeting of the American Society for Radiation Oncology, ARRO, Association of Residents in Radiation Oncology, ASTRO,

oncodaily.com/voices/astro...

On #WCRD, we're excited to announce the inaugural cohort of the International Clinical Research Scholars (ICRS) Program in partnership with Aortic-Africa!

Join us in celebrating their commitment: brnw.ch/21wW46w

Today, September 24th, is World Metastatic Colorectal Cancer Day (mCRC)- a day to raise awareness of the most advanced stage of cancer, honour the strength of those living with mCRC and remember those we’ve lost. 💙

🔗To learn more at about mCRC visit colorectalcancercanada.com

DHDP will help accelerate Canadian precision oncology researchers and data scientists tap into valuable big data. But what is DHDP?
DHDP is a pan-Canadian initiative led by
@terryfoxresearch.bsky.social, funded by Canada’s Strategic Innovation Fund through ISED. #WorldCancerResearchDay www.dhdp.ca

📢 CPE & @eortc.org launched the White Paper on Treatment Optimisation at the @europarl.europa.eu

By embedding Treatment Optimisation into EU frameworks, we can make treatments more effective, accessible, and sustainable for all.

🔗 Read more: lnkd.in/dmuWbaUv

Queen’s Department of Oncology Grand Rounds hears from the renowned Dr. Bishal Gyawali. Fantastic trainee-led editorial on how to meaningfully improve the success rate of phase 3 oncology trials academic.oup.com/jnci/article...

Common Sense Oncology principles for the design, analysis, and reporting of phase 3 randomised clinical trials Common Sense Oncology (CSO) prioritises treatments providing meaningful benefits for people with cancer. Here, we describe CSO principles aimed at improving the design, analysis, and reporting of rand...

Delighted to hear from the renowned Dr. Bishal Gyawali about Common Sense Oncology and his team’s work. Eg Common Sense Oncology principles for the design, analysis, and reporting of phase 3 randomised clinical trials www.thelancet.com/journals/lan...

Beyond the first course: Re-irradiation practices in Ontario — Insights from a provincial survey In the province of Ontario, Canada, radiation therapy is delivered through a publicly funded, distributed system comprising 15 Regional Cancer Centres (RCCs). These centres vary in their size and comp...

Beyond the first course: Re-irradiation practices in Ontario — Insights from a provincial survey - Technical Innovations and Patient Support in Radiation Oncology www.tipsro.science/article/S240...

Advancing Terry Fox's vision for cancer research Forty-five years after Terry Fox set out on his Marathon of Hope, his legacy continues to shape how cancer is studied and treated in Canada. That vision now drives the Marathon of Hope Cancer Centres ...

Queen's University: Advancing Terry Fox's vision for cancer research through the The Marathon of Hope Cancer Centres Network

healthsci.queensu.ca/stories/feat...

“These efforts position Queen’s and the SCRI as a leader in cancer genomics while directly improving care for patients,” says Dr. Simpson. “It demonstrates the impact that collaboration can have on both research and patient care.” – Dr. Amber Simpson
www.queensu.ca/gazette/stor...

What are your thoughts on using a home stool test for colorectal cancer screening?

Canadians aged 50–74 who have never been diagnosed with colorectal cancer are invited to take a short survey and share their views.
👉 www.surveymonkey.com/r/3HKLT3H (~10 mins)

#AI is set to be “an indispensable part of the toolkit” as we work to improve the diagnosis and treatment of skin cancer.

Using it effectively and responsibly comes with challenges, but we’re excited to see the benefits it will bring to patients.

Learn more here ⬇️
www.icr.ac.uk/research-and...

Queen's University. Common Sense Oncology Cancer Health Services Research Fellowship. Apply today to help build a cancer care system focused on outcomes that matter.

Applications for the 2026 Common Sense Oncology Cancer Health Services Research Fellowship will close on Sept 18, 2025 @ 4 pm EDT. If you are in the clinical or medical oncology field, this opportunity is for you!

View the posting online: tinyurl.com/37cdc5sy

#CommonSenseOncology #CancerCare

Patient, Caregiver, and Clinician Perspectives on Time Burdens of Cancer Care This qualitative analysis explores time-consuming aspects of cancer care that were perceived as burdensome, identifies the individuals most affected by the time burdens of cancer care, and evaluates t...

Congrats to Arjun Gupta and team on this much needed foundational work on ‘time toxicity’, out now in JAMA Network Open: jamanetwork.com/journals/jam...

Looking forward to getting the 🇦🇺 version out there soon!

📣 Join an ESTRO Focus Group!
✅ Apply now to become a Full Member of one of our Focus Groups:
🔹 Imaging
🔹 Oligometastatic Disease
🔹 Children & TYA
🔹 Haemato-Oncology
➡️ Contribute to clinical guidelines, scientific programmes, education, and more.
ℹ bit.ly/4nHXWMj
✏ Apply here: bit.ly/44OX0xZ

ECO’s Research Policy Network has launched a Green Paper on Optimising EU Investment in Cancer Research, and your opinion matters. 📢

👉 Deadline: World Cancer Research Day, 24 September

📝 Participate here: www.europeancancer.org/green-paper-...

A research paper titled "Patient-Reported Outcomes as Prognostic Indicators for Overall Survival in Cancer: A Systematic Review and Meta-Analysis" by Ryan S. Huang et al. Published in JAMA Oncology.

Patient-reported outcomes, such as higher health status and lower symptom burden, are independently associated with improved overall survival in cancer patients. ja.ma/3IeBPwZ

Accelerating precision medicine research by building a collaborative data sharing network.
Learn more in the Foundation's Year At A Glance.

EORTC Highlights New Research on Immunogenic Effects of Radiotherapy in Cancer Care - OncoDaily EORTC Highlights New Research on Immunogenic Effects of Radiotherapy in Cancer Care / André Abrunhosa-Branquinho, Angelo Filippo Monti, cancer, Coen Hurkmans,

EORTC Highlights New Research on Immunogenic Effects of Radiotherapy in Cancer Care

@eortc.org

oncodaily.com/insight/eort...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EORTC #Radiotherapy #RT

ChatGPT Performance as Patient-Facing Triaging Tool in Oncology | JCO Oncology Advances PURPOSEThis study assessed the diagnostic accuracy and medical appropriateness of a publicly available large language model (LLM) in triaging common clinical scenarios in breast oncology.METHODSFrom J...

Although further research & real world data are needed, initial results are promising & provide a starting point for prospective clinical trials-
ChatGPT Performance as Patient-Facing Triaging Tool in Oncology ascopubs.org/doi/10.1200/...